Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 4,043,865 6.053% | 2,160,747![]() (+114.74%) | Filing History |
2024-02-08 10:11 am Purchase | 2023-12-29 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Wellington Management Group LLP | 3,245,105 4.860% | 440,620![]() (+15.71%) | Filing History |
2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BlackRock Inc. BLK | 5,345,114 8.000% | 1,427,625![]() (+36.44%) | Filing History |
2024-01-24 10:28 am Purchase | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | STATE STREET CORP STT | 3,563,736 5.340% | 3,563,736![]() (New Position) | Filing History |
2023-09-18 4:24 pm Purchase | 2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,727,952 5.600% | 3,727,952![]() (New Position) | Filing History |
2023-02-14 4:12 pm Unchanged | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 3,196,876 5.900% | 0 (Unchanged) | Filing History |
2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BRAIDWELL LP | 3,469,674 6.450% | 3,469,674![]() (New Position) | Filing History |
2023-02-14 11:58 am Sale | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BIOTECHNOLOGY VALUE FUND L P | 2,736,613 5.100% | -267,266![]() (-8.90%) | Filing History |
2023-02-09 09:59 am Sale | 2023-02-09 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 1,883,118 3.499% | -1,839,176![]() (-49.41%) | Filing History |
2023-02-08 11:32 am Purchase | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 5,624,744 10.450% | 831,106![]() (+17.34%) | Filing History |
2023-02-06 2:51 pm Purchase | 2022-12-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Wellington Management Group LLP | 2,804,485 5.210% | 2,804,485![]() (New Position) | Filing History |
2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BlackRock Inc. BLK | 3,917,489 7.300% | 641,319![]() (+19.58%) | Filing History |
2022-04-25 7:02 pm Unchanged | 2022-04-25 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% | 0 (Unchanged) | Filing History |
2022-04-20 9:17 pm Purchase | 2022-04-18 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% | 1,674,151![]() (+45.75%) | Filing History |
2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital, LP | 1,900,000 4.000% | 1,334![]() (+0.07%) | Filing History |
2022-02-11 5:22 pm Sale | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII, LLC | 0 0.000% | -1,819,600![]() (Position Closed) | Filing History |
2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 3,196,876 6.700% | 443,309![]() (+16.10%) | Filing History |
2022-02-10 8:21 pm Sale | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Versant Venture Capital V L.P. | 382,961 0.800% | -1,512,041![]() (-79.79%) | Filing History |
2022-02-10 4:30 pm Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Struthers Richard Scott | 1,978,334 4.200% | 274,339![]() (+16.10%) | Filing History |
2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BlackRock Inc. BLK | 3,276,170 6.900% | 1,162,975![]() (+55.03%) | Filing History |